Translation and validation of the Persian version of Godin Leisure-Time Exercise Questionnaire in patients with multiple sclerosis.


Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
05 Nov 2021
Historique:
received: 12 04 2021
accepted: 25 10 2021
entrez: 6 11 2021
pubmed: 7 11 2021
medline: 10 11 2021
Statut: epublish

Résumé

Psychometric study. The purpose of this study is to translate, culturally adapt and evaluate the validity and reliability of the Persian (Farsi) version of GLTEQ in patients with multiple sclerosis. This study had three phases, including translation of the questionnaire into Persian and making cultural adaptation, evaluation of pre-final version of questionnaire's comprehensibility in a pilot study, and investigation of reliability and validity of the final version of the translated questionnaire. Content validity, and convergent validity (correlations among the Persian version of GLTEQ and Global physical activity questionnaire (GPAQ), and international physical activity questionnaire (IPAQ)) and after all test-retest reliability were studied. The subjects were 87 MS patients. The Persian version demonstrated moderate to good convergent validity; the correlation coefficient between the Persian version and GPAQ was r=0.64 (p<0.001), and between the Persian version and IPAQ was r=0.59 (p<0.001). The test-retest reliability was strong (Intra-class Correlation (ICC) value ranged between 0.908 and 0.992). Besides, its face validity and content validity were acceptable. The Persian version of GLTEQ is a valid and reliable instrument to assess physical activity in patients with MS. This questionnaire can be a step toward standardization of physical activity measurement in patients with MS. Also, in research, it provides the possibilities to carry on a comparative study across cultures using the same outcome measure.

Identifiants

pubmed: 34740328
doi: 10.1186/s12883-021-02465-5
pii: 10.1186/s12883-021-02465-5
pmc: PMC8569962
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

431

Informations de copyright

© 2021. The Author(s).

Références

Mult Scler Relat Disord. 2018 Feb;20:169-177
pubmed: 29414293
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
Disabil Rehabil. 2019 Jun;41(11):1243-1267
pubmed: 29343122
Curr Med Res Opin. 2014 Sep;30(9):1857-62
pubmed: 24803286
Arch Phys Med Rehabil. 2018 Oct;99(10):2059-2075
pubmed: 29337021
Cochrane Database Syst Rev. 2015 Sep 11;(9):CD009956
pubmed: 26358158
Arch Phys Med Rehabil. 2015 Jul;96(7):1329-38
pubmed: 25596001
Nurs Res. 1986 Nov-Dec;35(6):382-5
pubmed: 3640358
Iran J Public Health. 2017 May;46(5):699-704
pubmed: 28560202
Minerva Med. 2008 Apr;99(2):157-65
pubmed: 18431324
Turk J Emerg Med. 2018 Aug 07;18(3):91-93
pubmed: 30191186
BMC Neurol. 2017 Sep 16;17(1):185
pubmed: 28915856
Neuroepidemiology. 2006;27(1):39-44
pubmed: 16804333
Arch Neurol. 1988 Apr;45(4):435-7
pubmed: 3355400
Neurol Ther. 2019 Jun;8(1):5-11
pubmed: 30980257
Mult Scler Relat Disord. 2016 Nov;10:26-29
pubmed: 27919494
Int J Exerc Sci. 2016;9(5):587-598
pubmed: 29177023
Sports Med. 2004;34(15):1077-100
pubmed: 15575796
Scand J Med Sci Sports. 2018 Aug;28(8):1916-1924
pubmed: 29528518
Iran J Neurol. 2017 Jan 5;16(1):34-40
pubmed: 28717432
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
Am J Phys Med Rehabil. 2017 Oct;96(10):748-761
pubmed: 28398967
Psychol Health Med. 2009 Jan;14(1):111-24
pubmed: 19085318
Curr Neurol Neurosci Rep. 2015 Sep;15(9):62
pubmed: 26223831
Neuroepidemiology. 1994;13(1-2):1-7
pubmed: 8190200
Med Sci Sports Exerc. 1997 Apr;29(4):517-23
pubmed: 9107635
BMC Neurol. 2017 Dec 1;17(1):204
pubmed: 29191168
J Phys Act Health. 2011 Jan;8(1):27-35
pubmed: 21297182
J Patient Rep Outcomes. 2017;2(1):12
pubmed: 29757299
Clin Rehabil. 2007 Jul;21(7):628-39
pubmed: 17702705
Ann Neurol. 2000 Jun;47(6):707-17
pubmed: 10852536
Arch Phys Med Rehabil. 2016 Apr;97(4):633-645.e29
pubmed: 26751247
Int J Behav Nutr Phys Act. 2011 Oct 21;8:115
pubmed: 22018588
PLoS One. 2016 Jun 08;11(6):e0156288
pubmed: 27275947
Int J Public Health. 2014 Apr;59(2):231-41
pubmed: 24346180
J Phys Act Health. 2018 Apr 1;15(4):269-278
pubmed: 29421974
Asian J Sports Med. 2011 Jun;2(2):106-16
pubmed: 22375226
P T. 2012 Mar;37(3):175-84
pubmed: 22605909
Rehabil Psychol. 2018 Feb;63(1):77-82
pubmed: 28758772
Qual Life Res. 2016 Jun;25(6):1605-11
pubmed: 26660145
Res Q Exerc Sport. 2015 Jun;86(2):117-29
pubmed: 25874730
Anesth Analg. 2018 May;126(5):1763-1768
pubmed: 29481436

Auteurs

Mohammad-Reza Fattahi (MR)

Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran.
Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Department of Sports and Exercise Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Pardis Noormohammadpour (P)

Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Department of Sports and Exercise Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Meysam Ramezani (M)

Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sports and Exercise Medicine, MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Ali Sahraian (MA)

Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran.
Neurology, MS Fellowship, MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Ali Mansournia (MA)

Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Mastaneh Rajabian Tabesh (MR)

PHD Candidate in Sport Physiology Cardiac Primary Prevention Research Center (CPPRC), Heart Centre hospital, Tehran University of Medical Sciences, Tehran, Iran.

Mohamed Ali Mesgarof (MA)

Department of Sports and Exercise Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Maryam Abolhasani (M)

Sports and Exercise Medicine, MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. dr_m_abolhasani@yahoo.com.
Department of Sports Medicine, Sports and Exercise medicine, Sina MS Research Center, Sina Hospital, Hassan Abad Square, Tehran, Iran. dr_m_abolhasani@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH